Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Mallinckrodt
Express Scripts
Moodys

Last Updated: July 1, 2022

CLINICAL TRIALS PROFILE FOR POLIDOCANOL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Polidocanol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00161915 ↗ Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices Completed Baxter Healthcare Corporation Phase 3 2000-12-01 The purpose of this study was to assess whether endoscopic sclerotherapy with Fibrin Sealant was superior to ligature, with or without Polidocanol, in achieving hemostasis in bleeding esophageal varices and preventing rebleeding. Therapeutic success was defined as survival of the first seven days without clinically significant bleeding.
NCT00377910 ↗ The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy Completed Aarhus University Hospital Phase 4 2008-03-01 Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
NCT00377910 ↗ The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy Completed Northern Orthopaedic Division, Denmark Phase 4 2008-03-01 Chronic achilles tendinopathy is a common disease especially in adults. The golden standard in treatment has up to now been excentric exercises but with varying success. A new hypothesis is that this chronic pain is due to neo vascularisation. In a pilot study sclerosing injections with polidocanol have had a successful efficacy. Our aim is to study the efficacy of polidocanol as a treatment in a randomised controlled setting on a larger scale.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Polidocanol

Condition Name

Condition Name for Polidocanol
Intervention Trials
Varicose Veins 10
Leg Ulcer 1
Melanoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Polidocanol
Intervention Trials
Varicose Veins 12
Hemorrhoids 3
Tendinopathy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Polidocanol

Trials by Country

Trials by Country for Polidocanol
Location Trials
United States 38
United Kingdom 2
Portugal 2
Germany 2
Brazil 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Polidocanol
Location Trials
Washington 6
North Carolina 4
Florida 3
New York 3
California 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Polidocanol

Clinical Trial Phase

Clinical Trial Phase for Polidocanol
Clinical Trial Phase Trials
Phase 4 7
Phase 3 4
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Polidocanol
Clinical Trial Phase Trials
Completed 14
Unknown status 4
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Polidocanol

Sponsor Name

Sponsor Name for Polidocanol
Sponsor Trials
BTG International Inc. 9
Boston Scientific Corporation 7
Fundação de Amparo à Pesquisa do Estado de São Paulo 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Polidocanol
Sponsor Trials
Other 32
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
Dow
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.